Utilization of commercial collagens for preparing well-differentiated human beta cells for confocal microscopy.
CNA35
lipid droplets
mitochondria
type IV collagen
type V collagen
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
03
2023
accepted:
09
05
2023
medline:
13
6
2023
pubmed:
12
6
2023
entrez:
12
6
2023
Statut:
epublish
Résumé
With technical advances, confocal and super-resolution microscopy have become powerful tools to dissect cellular pathophysiology. Cell attachment to glass surfaces compatible with advanced imaging is critical prerequisite but remains a considerable challenge for human beta cells. Recently, Phelps et al. reported that human beta cells plated on type IV collagen (Col IV) and cultured in neuronal medium preserve beta cell characteristics. We examined human islet cells plated on two commercial sources of Col IV (C6745 and C5533) and type V collagen (Col V) for differences in cell morphology by confocal microscopy and secretory function by glucose-stimulated insulin secretion (GSIS). Collagens were authenticated by mass spectrometry and fluorescent collagen-binding adhesion protein CNA35. All three preparations allowed attachment of beta cells with high nuclear localization of NKX6.1, indicating a well-differentiated status. All collagen preparations supported robust GSIS. However, the morphology of islet cells differed between the 3 preparations. C5533 showed preferable features as an imaging platform with the greatest cell spread and limited stacking of cells followed by Col V and C6745. A significant difference in attachment behavior of C6745 was attributed to the low collagen contents of this preparation indicating importance of authentication of coating material. Human islet cells plated on C5533 showed dynamic changes in mitochondria and lipid droplets (LDs) in response to an uncoupling agent 2-[2-[4-(trifluoromethoxy)phenyl]hydrazinylidene]-propanedinitrile (FCCP) or high glucose + oleic acid. An authenticated preparation of Col IV provides a simple platform to apply advanced imaging for studies of human islet cell function and morphology.
Identifiants
pubmed: 37305047
doi: 10.3389/fendo.2023.1187216
pmc: PMC10248405
doi:
Substances chimiques
Collagen
9007-34-5
Collagen Type V
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1187216Subventions
Organisme : BLRD VA
ID : I01 BX005107
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK090490
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK098085
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR025439
Pays : United States
Informations de copyright
Copyright © 2023 Brennecke, Yang, Liu, Ilerisoy, Ilerisoy, Joglekar, Kim, Peachee, Richtsmeier, Stephens, Sander, Strack, Moninger, Ankrum and Imai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Diabetologia. 2020 Dec;63(12):2628-2640
pubmed: 32960311
Mol Aspects Med. 2015 Apr;42:91-104
pubmed: 25659350
Sci Rep. 2019 Apr 1;9(1):5403
pubmed: 30932004
Trends Endocrinol Metab. 2013 Jul;24(7):351-60
pubmed: 23484621
Mol Metab. 2017 Jul 08;6(9):943-957
pubmed: 28951820
JCI Insight. 2021 May 10;6(9):
pubmed: 33784258
Nat Rev Mol Cell Biol. 2014 Dec;15(12):771-85
pubmed: 25370693
Sci Rep. 2021 Jan 27;11(1):2378
pubmed: 33504882
Diabetologia. 2018 Jun;61(6):1261-1272
pubmed: 29306997
Diabetes. 2020 Mar;69(3):279-290
pubmed: 32079704
Cell Metab. 2019 Mar 5;29(3):745-754.e4
pubmed: 30449685
Physiol Rep. 2018 Oct;6(20):e13907
pubmed: 30370689
Diabetologia. 2008 Jul;51(7):1181-91
pubmed: 18438639
Coll Relat Res. 1981 Jul;1(4):337-43
pubmed: 7346227
Mol Metab. 2019 Sep;27S:S92-S103
pubmed: 31500836
Am J Physiol Endocrinol Metab. 2015 Oct 1;309(7):E611-20
pubmed: 26286869
J Cell Sci. 2012 Sep 1;125(Pt 17):4067-76
pubmed: 22685330
Endocrinology. 2019 Aug 1;160(8):1885-1894
pubmed: 31271410
Endocrinology. 2022 Mar 1;163(3):
pubmed: 35086144
Biol Cell. 2017 Jun;109(6):223-237
pubmed: 28266044
J Neurosci Methods. 2022 Apr 15;372:109558
pubmed: 35271874
Anal Biochem. 2006 Mar 15;350(2):177-85
pubmed: 16476406
Methods Cell Biol. 2018;143:171-185
pubmed: 29310777
J Infect Dis. 2004 Jun 15;189(12):2323-33
pubmed: 15181582
J Clin Invest. 2011 Feb;121(2):769-83
pubmed: 21293061
Endocr Rev. 2021 Sep 28;42(5):605-657
pubmed: 33844836
Diabetologia. 2019 Feb;62(2):212-222
pubmed: 30547228
Cell Death Differ. 2010 Nov;17(11):1785-94
pubmed: 20489733
Diabetologia. 2002 Jun;45(6):841-50
pubmed: 12107728
Biomaterials. 2020 Mar;233:119673
pubmed: 31866049
J Biol Chem. 2013 Apr 26;288(17):12353-65
pubmed: 23486469
Biophys Rev. 2021 Aug 31;13(6):1199-1217
pubmed: 35047093
Diabetologia. 2021 Mar;64(3):618-629
pubmed: 33399909
Sci Rep. 2017 Apr 12;7:45961
pubmed: 28401888
Science. 2004 Dec 24;306(5705):2261-4
pubmed: 15564314
EMBO J. 2005 Dec 21;24(24):4224-36
pubmed: 16362049
J Diabetes Res. 2016;2016:4396756
pubmed: 27195301
Sci Signal. 2010 Feb 23;3(110):pe7
pubmed: 20179270
J Mol Biol. 2020 Mar 6;432(5):1407-1418
pubmed: 31711959
Curr Protoc Cell Biol. 2013 Jun;Chapter 4:4.11.1-4.11.24
pubmed: 23728746
Diabetes. 2002 Feb;51 Suppl 1:S25-8
pubmed: 11815453
Connect Tissue Res. 2022 Sep;63(5):498-513
pubmed: 35129018
Histochem Cell Biol. 2022 Sep;158(3):203-211
pubmed: 35829815
Diabetes. 2021 May;70(5):1051-1060
pubmed: 33947722